Francisco Javier
López González
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (10)
2019
-
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy
Epilepsy and Behavior, Vol. 97, pp. 51-59
2018
-
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752
2017
-
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
2016
-
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
Epilepsy Research, Vol. 126, pp. 201-210
2015
-
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study
Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131
2014
-
Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study
Epilepsy and Behavior, Vol. 36, pp. 144-152
-
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218